Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|May 10, 2018
The European Medicines Agency's approval of new medicines for type 2 diabetesEberhard Blind, Heidi Janssen, Kristina Dunder, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2011
Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutterIrina Savelieva, Paulus Kirchhof, Nicholas Danchin, et al.
BMC Family Practice|May 5, 2005
Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?Willeke N Kasje, Petra Denig, Pieter A de Graeff, et al.
International Journal of Technology Assessment in Health Care|April 19, 2003
Connecting pre-marketing clinical research and medical practice: opinion-based study of core issues and possible changes in drug regulationNicolien F Wieringa, Jules L Peschar, Petra Denig, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 13, 2013
Risk perception of prescription drugs: results of a survey among experts in the European regulatory networkAndrea R Beyer, Barbara Fasolo, Lawrence D Phillips, et al.
European Journal of Clinical Pharmacology|March 12, 2005
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel studyWilleke N Kasje, Petra Denig, Roy E Stewart, et al.
Journal of Evaluation in Clinical Practice|November 15, 2006
An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practiceWilleke N Kasje, Petra Denig, Roy E Stewart, et al.
Blood Pressure. Supplement|June 13, 2003
Effects of nifedipine on carotid and femoral arterial wall thickness in previously untreated hypertensive patientsWillem F Terpstra, Johan F May, Andries J Smit, et al.
Drug Safety|October 11, 2011
Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment ReportsArna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Drug Safety|June 26, 2013
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the NetherlandsSigrid Piening, Pieter A de Graeff, Sabine M J M Straus, et al.
Pageof 3